Latest Breaking News On - Vivo capital - Page 8 : comparemela.com

Regulus Therapeutics Inc (NASDAQ:RGLS) Short Interest Down 32 9% in April

Regulus Therapeutics Inc (NASDAQ:RGLS) Short Interest Down 32 9% in April
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United statesRegulus therapeutics incVanguard group incVivo capitalWells fargo companyRegulus therapeutics company profileVictory capital management incCanaccord genuity groupRegulus therapeuticsGet free reportCapital managementGenuity groupTherapeutics incRegulus therapeutics daily

HC Wainwright Increases Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $28 00

HC Wainwright Increases Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $28 00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Cyrus harmonAnalyst recommendations for olema pharmaceuticalsNews ratings for olema pharmaceuticals dailyOlema pharmaceuticals company profileOlema pharmaceuticals incOlema pharmaceuticalsSecurities exchange commissionVivo capitalInstitutional investors weigh in on olema pharmaceuticalsDimensional fund advisorsVanguard group incOlema pharmaceuticals trading downGoldman sachs groupPolar capital holdings plcFree reportOne financial

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Expected to Earn Q4 2024 Earnings of $0 07 Per Share

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Expected to Earn Q4 2024 Earnings of $0 07 Per Share
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United statesPiper sandlerGendell jeffreyLeerink partnrsWealth effectsAvadel pharmaceuticalsVivo capitalInstitutional trading of avadel pharmaceuticalsAvadel pharmaceuticals trading downNews ratings for avadel pharmaceuticals dailyNeedham companyFree reportAvadel pharmaceuticalGet free reportPharmaceuticals trading downBrandes investment partners

Lifesci Capital Comments on Avadel Pharmaceuticals plc s Q4 2024 Earnings (NASDAQ:AVDL)

Lifesci Capital Comments on Avadel Pharmaceuticals plc s Q4 2024 Earnings (NASDAQ:AVDL)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesPiper sandlerGendell jeffreyAvadel pharmaceuticalsWealth effectsVivo capitalAvadel pharmaceuticals trading downHedge funds weigh in on avadel pharmaceuticalsNews ratings for avadel pharmaceuticals dailyNeedham companyFree reportLifesci capitalAvadel pharmaceuticalGet free reportPharmaceuticals trading downBrandes investment partners

Soleno Therapeutics, Inc (NASDAQ:SLNO) Given Consensus Rating of Buy by Analysts

Soleno Therapeutics, Inc (NASDAQ:SLNO) Given Consensus Rating of Buy by Analysts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Robertw bairdPiper sandlerStifel nicolausBhatnagar anishVivo opportunity llcVivo capitalSoleno therapeutics company profileCarlyle group incSoleno therapeutics incSecurities exchange commissionSoleno therapeuticsGet free reportVivo opportunityExchange commissionCapital partnersPoint capital